Recombinant STEAP1 (Vandortuzumab Biosimilar) antibody

Catalog No. ABIN7598082

This Humanized Chimeric antibody specifically detects STEAP1 (Vandortuzumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant STEAP1 (Vandortuzumab Biosimilar) antibody (ABIN7598082)

Target: STEAP1 (Vandortuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This STEAP1 (Vandortuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-STEAP1 (Vandortuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Vandortuzumab Biosimilar Antibody

Specificity: PRSS24, STEAP1, STEAP, Metalloreductase STEAP1, Six-transmembrane epithelial antigen of prostate 1

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for STEAP1 (Vandortuzumab Biosimilar)

Target: STEAP1 (Vandortuzumab Biosimilar)

Alternative Name: Vandortuzumab Biosimilar

Target Type: Biosimilar

Background: PRSS24, STEAP1, STEAP, Metalloreductase STEAP1, Six-transmembrane epithelial antigen of prostate 1

UniProt: Q9UHE8

CAS-No: 1557989-52-2